Rallybio Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019
Cash & Equivalents	24.49	56.96	175.33	140.23	19.46
Short-Term Investments	85.44	112.04	0	0	0
Cash & Cash Equivalents	109.93	168.99	175.33	140.23	19.46
Cash Growth	-34.95%	-3.62%	25.03%	620.70%	-
Other Current Assets	4.86	10.5	5.54	1.03	1.46
Total Current Assets	114.79	179.5	180.87	141.26	20.92
Property, Plant & Equipment	0.59	0.91	0.51	0.29	0.2
Long-Term Investments	0.24	0.03	0.81	0.31	0.49
Total Long-Term Assets	0.83	0.94	1.32	0.6	0.69
Total Assets	115.62	180.44	182.19	141.86	21.61
Accounts Payable	0.98	1.11	0.6	1.58	0.86
Current Debt	0.22	0.18	0	0	0
Other Current Liabilities	8.07	9.45	5.95	4.26	2.95
Total Current Liabilities	9.26	10.74	6.55	5.84	3.81
Long-Term Debt	0.17	0.37	0	0	0
Other Long-Term Liabilities	0	0	0.03	0.01	0.94
Total Long-Term Liabilities	0.17	0.37	0.03	0.01	0.94
Total Liabilities	9.44	11.12	6.58	5.86	4.75
Total Debt	0.39	0.56	0	0	0
Debt Growth	-29.37%	-	-	-	-
Retained Earnings	-235.25	-160.68	-94.03	-47.01	-20.57
Comprehensive Income	0.02	-0.21	0	0	0
Shareholders' Equity	106.18	169.32	175.6	136	-20.28
Net Cash / Debt	109.54	168.44	175.33	140.23	19.46
Net Cash / Debt Growth	-34.97%	-3.93%	25.03%	620.70%	-
Net Cash Per Share	2.71	5.29	6.87	8.06	11.34
Working Capital	105.53	168.75	174.32	135.42	17.11
Book Value Per Share	2.63	5.32	6.88	7.82	-11.82

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).